Visfatin in human pregnancy: maternal gestational diabetes vis-a-vis neonatal birthweight Article

Mazaki-Tovi, Shali, Romero, Roberto, Kusanovic, Juan Pedro et al. (2009). Visfatin in human pregnancy: maternal gestational diabetes vis-a-vis neonatal birthweight . JOURNAL OF PERINATAL MEDICINE, 37(3), 218-231. 10.1515/JPM.2009.053

cited authors

  • Mazaki-Tovi, Shali; Romero, Roberto; Kusanovic, Juan Pedro; Vaisbuch, Edi; Erez, Offer; Than, Nandor Gabor; Chaiworapongsa, Tinnakorn; Nhan-Chang, Chia-Ling; Pacora, Percy; Gotsch, Francesca; Yeo, Lami; Kim, Sun Kwon; Edwin, Samuel S; Hassan, Sonia S; Mittal, Pooja

authors

publication date

  • May 1, 2009

published in

keywords

  • ABNORMAL GLUCOSE-TOLERANCE
  • ADIPOSE-TISSUE
  • COLONY-ENHANCING FACTOR
  • FETAL MEMBRANE DISTENSION
  • INSULIN-RESISTANCE
  • LINKED-IMMUNOSORBENT-ASSAY
  • Life Sciences & Biomedicine
  • MESSENGER-RNA EXPRESSION
  • NECROSIS-FACTOR-ALPHA
  • Obstetrics & Gynecology
  • PLASMA ADIPONECTIN CONCENTRATIONS
  • Pediatrics
  • SERUM VISFATIN
  • Science & Technology
  • adipokine
  • adipose tissue
  • appropriate-for-gestational-age (AGA)
  • gestational diabetes mellitus (GDM)
  • large-for-gestational-age (LGA)
  • pre-B cell colony-enhancing factor (PBEF)
  • visfatin

Digital Object Identifier (DOI)

publisher

  • WALTER DE GRUYTER GMBH

start page

  • 218

end page

  • 231

volume

  • 37

issue

  • 3